Millennium Management’s Firefly Neuroscience AIFF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-10,051
Closed -$28.4K 6556
2025
Q2
$28.4K Buy
+10,051
New +$31.9K ﹤0.01% 5656
2025
Q1
Sell
-43,314
Closed -$115K 6528
2024
Q4
$115K Sell
43,314
-13,620
-24% -$42.2K ﹤0.01% 5451
2024
Q3
$173K Buy
+56,934
New +$299K ﹤0.01% 5486
2022
Q3
Sell
-515
Closed -$21K 7577
2022
Q2
$21K Buy
+515
New +$49.7K ﹤0.01% 6476

Other funds holding AIFF

Millennium Management's AIFF Position: Q3 2025 in Review

Millennium Management sold out of Firefly Neuroscience (AIFF) in Q3 2025, closing a stake of 10,051 shares — an estimated $28.4K sold.

Millennium Management first reported a position in AIFF in Q2 2022 and held it in 4 quarters. The position peaked at $173K in Q3 2024. 18 funds tracked by Wall St. Rank hold AIFF as of Q3 2025.

  • Millennium Management reported no remaining Firefly Neuroscience position as of Q3 2025 after selling out during the quarter.
  • Millennium Management sold 10,051 Firefly Neuroscience shares in Q3 2025, an estimated $28.4K.
  • Millennium Management first reported a position in Firefly Neuroscience in Q2 2022 and held it in 4 quarters.
  • Millennium Management's Firefly Neuroscience position peaked at $173K in Q3 2024.
  • 18 funds tracked by Wall St. Rank held Firefly Neuroscience as of Q3 2025.

Based on Millennium Management's 13F filing for Q3 2025, filed 14 Nov 2025.